| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/24/2008 | CN100420945C Method and device for detecting and insolating pharmacological compounds being contained in substance mixtures |
| 09/24/2008 | CN100420698C Process for extracting amygdalin and use thereof |
| 09/24/2008 | CN100420690C Benzofuran compound, prepn. method and application thereof |
| 09/24/2008 | CN100420689C Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant |
| 09/24/2008 | CN100420688C Pyrimido[4,5-d]pyrimidine derivatives with anticancer activity |
| 09/24/2008 | CN100420687C Pyridino [2, 3-D] pyrimidine derivatives as selective KDR and FGFR inhibitors |
| 09/24/2008 | CN100420683C Armiharisin succinic mono ester with cholagogic effect, and its salt and medicinal composition |
| 09/24/2008 | CN100420679C Novel compound, bacteria strain and method for producing novel compound using the strain |
| 09/24/2008 | CN100420677C Substituted aryl methylene sulfonylated aza cyclo-pentanone compounds, its medicine compositions and its preparing process and use |
| 09/24/2008 | CN100420672C Selective COX-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines |
| 09/24/2008 | CN100420483C Sigma ligands for neuronal regeneration and functional recovery |
| 09/24/2008 | CN100420482C Method for short-term and long-term drug dosimetry |
| 09/24/2008 | CN100420460C Chinese medicinal compsns. for treating burn and scald, its prepn. and usage |
| 09/24/2008 | CN100420459C Lower alcohol-insoluble extract of hovenia dulcis thunb and a polysaccharide isolated therefrom |
| 09/24/2008 | CN100420458C Externally applied Chinese traditional medicine formulation and its preparing method |
| 09/24/2008 | CN100420453C Solid dispersion of extractive of general flavone of Balsamiferou Blumea Herb |
| 09/24/2008 | CN100420452C Application of total asiaticoside in preparing medicine for preventing and treating membranous nephropathy |
| 09/24/2008 | CN100420447C Medicine for treating gastropathy and duodenal ulcer |
| 09/24/2008 | CN100420446C Surgical flush fluid and its preparing process and application |
| 09/24/2008 | CN100420445C Fatty cream composition for maligant splanchnocoele hydrops and its preparing method |
| 09/24/2008 | CN100420444C Pennogenic compound liquid molecular dispersible preparation |
| 09/24/2008 | CN100420443C Nucleotide analog composition and synthesis method |
| 09/24/2008 | CN100420442C Pharmaceutical composition of scutellarin and baicalin with synergistic tumor resistance function |
| 09/24/2008 | CN100420441C Use of flavone in preparing medicine for improving uric acid excretion |
| 09/24/2008 | CN100420440C Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same |
| 09/24/2008 | CN100420439C Use of biguanide derivatives for making a medicine having a wound healing effect |
| 09/24/2008 | CN100420437C Tetramethylpyrazine phosphate slow-release micro-pill and its preparing method |
| 09/24/2008 | CN100420391C Health-care food with anti-oxidation and lowering weight functions |
| 09/23/2008 | US7428705 Web map tool |
| 09/23/2008 | US7427689 ErbB-2 selective small molecule kinase inhibitors |
| 09/23/2008 | US7427683 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer |
| 09/23/2008 | US7427682 Indole derivatives as selective androgen receptor modulators (SARMS) |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427672 Artificial nucleic acids of n-o bond crosslinkage type |
| 09/23/2008 | US7427639 β2-adrenergic receptor agonists |
| 09/23/2008 | US7427638 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/23/2008 | US7427637 Kinesin spindle protein (KSP) inhibitors; antiproliferative and -carcinogenic agents; side effects reduction; used with an estrogen receptor modulator; e.g. bicyclic dihydropyrrole derivatives |
| 09/23/2008 | US7427636 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups |
| 09/23/2008 | US7427635 2-[(S)-2-((S)-2,5-dioxo-4-phenyl-imidazolidin-1-yl)-4-methyl-pentanoylamino]-thiazole-4-carboxylic acid methyl ester; mitogen activated protein/extracellular signal regulated kinase kinase inhibitor; anticarcinogenic agent, cognition activator, nervous and autoimmune system disorders |
| 09/23/2008 | US7427634 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 09/23/2008 | US7427633 Antibiotic for gramnegative bacteria; prepared as an aerosolable saline solution |
| 09/23/2008 | US7427632 Factor Xa inhibitors |
| 09/23/2008 | US7427631 especially as inhibitors of MMP12 |
| 09/23/2008 | US7427630 1-{1-[1-(4-Methoxy-2-methylphenyl)-6-methyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-4-yl]-1H-pyrazol-3-yl}imidazolidin-2-one; potent; to treat central nervous system disorders; antidepressants; Anxiolytic agents; mood disorders; anagesics; gastrointestinal disorders like irritable bowel syndrome |
| 09/23/2008 | US7427629 Immunostimulatory compositions and methods of stimulating an immune response |
| 09/23/2008 | US7427628 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents |
| 09/23/2008 | US7427627 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds |
| 09/23/2008 | US7427626 useful in Pharmaceutical medicines or pharmacological tools; cytostatic agents; antiproliferative/antineoplastic agents; 2-Anilino-4-[1-isopropyl-2-(hydroxyiminomethyl)imidazol-5-yl]pyrimidine; rheumatoid arthritis; breast cancer |
| 09/23/2008 | US7427625 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors |
| 09/23/2008 | US7427624 with improved pharmacological properties and pharmacokinetic properties, oral bioavailability, greater potency and extended effective half-life in vivo; Crohn's disease, psoriasis, rheumatoid arthritis, T-cell lymphomas, T-cell leukemia, solid tumors, transplant tissue rejection, autoimmune diseeases |
| 09/23/2008 | US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof |
| 09/23/2008 | US7427622 Method of making and using theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate and mixtures thereof |
| 09/23/2008 | US7427621 neurodegenerative diseases: Alzheimer's disease; amyloid plague |
| 09/23/2008 | US7427620 4-{4-[4-{4-[2-(2-pyridinyl)-2-(1 H-1,2,4-triazol- 1 -yl-methyl)- 1 ,3-dioxolan-4-yl-methoxy]phenyl}- 1-piperazinyl]-phenyl}-2-( 1-methyl)-propyl-2,4-dihydro-3H-1,2,4-triazol-3-one; better toxicological profile and of reduced interaction with other drugs; good solubility in water, bioavailability |
| 09/23/2008 | US7427619 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 09/23/2008 | US7427618 e.g. 2-[3-(4-ethynylphenyl)ureido]-N-[4-(3-oxomorpholin-4-yl)phenyl]valeramide; anticoagulant, antitumor factor; thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, claudicatio intermittens, or migraine |
| 09/23/2008 | US7427617 e.g. 2-[1-(2-Fluorobenzyl)-1H-indazol-3-yl]-5-(3-oxa-9-azabicyclo[3.3.1]non-9-yl)-4pyrimidinylamine; soluble guanylate cyclase stimulant; neurodegenerative diseases, cognition activator; Alhzeimer's, Parkinson's disease, Pick's syndrome, multiple sclerosis, HIV dementia, schizophrenia |
| 09/23/2008 | US7427616 e.g. 8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine9-methyl-8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine; Tie2 receptor tyrosine kinase and angiogenesis inhibitor; diabetic retinopathy, psoriasis, cancer, rheumatoid arthritis, atheroma, Kaposi's sarcoma and haemangioma |
| 09/23/2008 | US7427615 3-substituted-4-pyrimidone derivatives |
| 09/23/2008 | US7427614 treatment of glaucoma or ocular hypertension; N-substituted hexahydropyrimidin-2-ones, perhydro-1,3-oxazin-2-ones and perhydro-1,3-thiazin-2-ones |
| 09/23/2008 | US7427613 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 09/23/2008 | US7427612 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 09/23/2008 | US7427610 e.g. 17 beta -Difluoromethyl-2-methoxy-estra-1,3,5(10)-trien-3-yl sulfamate; tubulin polymerization inhibitor; breast, prostate, colon, non-small-cell-lung cancer and primary dermal microvascular endothelial cell proliferation |
| 09/23/2008 | US7427609 Menopause; hormone replacement therapy; controlling dosage |
| 09/23/2008 | US7427608 Protection against and treatment of hearing loss |
| 09/23/2008 | US7427606 Method to reduce inflammatory response in transplanted tissue |
| 09/23/2008 | US7427605 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof |
| 09/23/2008 | US7427604 preventing avian coccidiosis; vaccine; host cell |
| 09/23/2008 | US7427603 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 09/23/2008 | US7427601 Method for treating tremor |
| 09/23/2008 | US7427600 mesalamine covalently attached to carrier peptide at C-terminus, interspersed and/or side chain; releasing into bloodstream; reducing dosage |
| 09/23/2008 | US7427591 Suppression of immune response via inhibition of cathepsin S |
| 09/23/2008 | US7427589 Administering substance that inhibits a pro-inflammatory cytokine for prevention or reduction of scar tissue and/or adhesion formation |
| 09/23/2008 | US7427503 Transporting material through membranes of cells in trehalose culture; genetic engineering |
| 09/23/2008 | US7427418 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent |
| 09/23/2008 | US7427416 Methods of treating conditions using metal-containing materials |
| 09/23/2008 | US7427414 Modified release oral dosage form using co-polymer of polyvinyl acetate |
| 09/23/2008 | US7427413 Storage stability; uniformity bioavailability ; sustained release; solid phase crystallization; solvent saturation; recovering |
| 09/23/2008 | US7427412 Gel-based cosmetic composition |
| 09/23/2008 | US7427407 Cosmetics |
| 09/23/2008 | US7427406 Aerosols |
| 09/23/2008 | US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 09/23/2008 | US7427402 for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis; treatment to prevent such skin inflammatory disorders using antagonists of IL- 17A, IL-17F, IL-19, and/or IL-23 |
| 09/23/2008 | US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 09/23/2008 | US7426815 Method and apparatus for loading a container with a product |
| 09/23/2008 | CA2626142A1 Stabilised aqueous solutions of ergoline compounds |
| 09/23/2008 | CA2527666C Multi-layer drug delivery device and method of manufacturing same |
| 09/23/2008 | CA2483875C 6,11 bicyclic erythromycin derivatives |
| 09/23/2008 | CA2480800C Inhibitors of akt activity |
| 09/23/2008 | CA2450093C Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
| 09/23/2008 | CA2437820C Endomural therapy |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/23/2008 | CA2420952C A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)-1-methylethyl pentanoate |
| 09/23/2008 | CA2418313C Piperidine derivatives and agent comprising the derivative as active ingredient |
| 09/23/2008 | CA2416169C Compositions containing therapeutically active components having enhanced solubility |
| 09/23/2008 | CA2395541C New substituted piperidines, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/23/2008 | CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 09/23/2008 | CA2378390C Tixocortol pivalate suspension, collutorium based on it and packaging containing it |
| 09/23/2008 | CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof |
| 09/23/2008 | CA2372992C Selenium-containing pro-drugs for cancer therapy |